IDH2 and oligodendroglioma: Between the diffuse gliomas and their molecular alterations, more than 90% of oligodendrogliomas show 1p19q codeletion and an isocitrate dehydrogenase (IDH) mutation, which has become a genetic signature of oligodendroglioma.